Ind-Swift Laboratories Ltd Board Meeting Scheduled to Consider Fund Raising through Various Equity Issuance Methods
Ind-Swift Laboratories Limited has scheduled a meeting of its Board of Directors to consider and approve a proposal for raising funds. The meeting is set to take place on Friday, July 10, 2026.The primary agenda item for the Board includes reviewing and approving various options for fund generation through the issuance of one or more instruments. These instruments include equity shares or convertible securities, which could be raised via a Preferential Issue, Rights Issue, QIP, or any other suitable modality determined by the company. The proposal also involves the determination of pricing related to the funds.
In addition to the Board meeting announcement, the company confirmed that the trading window for its securities remains closed. This closure is due to the pending declaration of both unaudited standalone and consolidated financial results. The restriction on trading will remain in effect until 48 hours following the conclusion of the scheduled Board Meeting.
INDSWFTLAB Stock Price Movement
Ind-Swift Laboratories Limited shares shed 2.59% today, settling at ₹215.15 in the post-market session. The equity saw trading volume reach 802,407 shares, having traded within an intraday range bounded by a low of ₹212.85 and a high of ₹224.9.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.